Seya T, Nagasawa S, Atkinson J P
Center for Adult Diseases Osaka, Japan.
J Immunol. 1990 Mar 15;144(6):2312-20.
Membrane cofactor protein (MCP) of the C system is a widely distributed regulatory molecule with C3b/C4b binding and factor I-dependent cofactor activity. A rabbit polyclonal antibody was raised against purified human MCP, and it was found to also immunoprecipitate C4b-binding protein (C4bp). Other related complement regulatory proteins, factor H, C3b/C4b receptor, and decay-accelerating factor, were not recognized by this polyclonal antibody to MCP. The cross-reactive epitope was sensitive to reduction with 2-ME and about 3% of the anti-MCP antibody reacted with C4bp. The amino-terminal 48,000-Da, chymotryptic fragment of C4bp was recognized by the antibody to MCP. This fragment of C4bp contains a seven-amino acid peptide that is identical, in its sequence and its location in the third short consensus repeat, to one found in MCP. Two polyclonal antibodies to C4bp, one raised to native and the other to reduced C4bp, did not cross-react with MCP. In addition to this one-way cross-reaction with C4bp, a protein with a m.w. of approximately 60,000 (p60) was found in two of three C4bp preparations that also cross-reacted with antiserum to MCP. p60 was present in trace quantities in the C4bp preparation and was successfully isolated from plasma by C3b affinity chromatography. Its Mr was distinct from that of MCP and other known C3b/C4b binding proteins. Furthermore, p60 was isolated by two different procedures and such material possessed no detectable cofactor activity. Based on these results, p60 is a plasma C3b-binding protein that shares epitopes with C4bp and MCP, and is probably not a soluble form of MCP.
补体系统的膜辅因子蛋白(MCP)是一种广泛分布的调节分子,具有C3b/C4b结合活性和I因子依赖性辅因子活性。制备了针对纯化人MCP的兔多克隆抗体,发现该抗体也能免疫沉淀C4b结合蛋白(C4bp)。其他相关的补体调节蛋白,如H因子、C3b/C4b受体和衰变加速因子,均不被该抗MCP多克隆抗体识别。交叉反应表位对2-ME还原敏感,约3%的抗MCP抗体与C4bp反应。C4bp的氨基末端48,000Da胰凝乳蛋白酶片段可被抗MCP抗体识别。C4bp的该片段包含一个七氨基酸肽,其序列及其在第三个短共有重复序列中的位置与MCP中发现的一个肽相同。两种针对C4bp的多克隆抗体,一种针对天然C4bp,另一种针对还原型C4bp,均不与MCP发生交叉反应。除了与C4bp的这种单向交叉反应外,在三份C4bp制剂中的两份中还发现了一种分子量约为60,000(p60)的蛋白,该蛋白也与抗MCP抗血清发生交叉反应。p60在C4bp制剂中含量微量,通过C3b亲和层析从血浆中成功分离出来。其分子量与MCP和其他已知的C3b/C4b结合蛋白不同。此外,p60通过两种不同的方法分离得到,这种物质不具有可检测到的辅因子活性。基于这些结果,p60是一种血浆C3b结合蛋白,与C4bp和MCP共享表位,可能不是MCP的可溶性形式。